Abstract:AIM:To constructe a murine model of upregulation of Dectin?1 in the airway by intratracheal administration of Ad?m Dectin?1 and study on identification and security of the murine model. METHODS:BALB/c mice were divided into PBS group, Ad?EGFP group and Ad?mDectin?1 group, intratracheal adminis?trated with PBS, Ad?EGFP and Ad?mDectin?1 respectively. After administration, the levels of Dectin?1 mRNA in lung tissue were tested by real?time PCR and immunohistochemitry, the levels of IL?6 in lung homogenate and serum were detected by ELISA, distribution of adenovirus vector in lung and liver was detected by confocal. RESULTS:At day 3 after administration of Ad?mDec?tin?1, the Dectin?1 mRNA expression was obviously increase in mice treated with Ad?mDectin?1, and was resulted in nearly eight?een fold increase compared with mice treated by Ad?EGFP or PBS. For mice treated with Ad?mDectin?1, immunohistochemistry results showed strong immunostaining in the airways epithelium in bronchioles and nearly negative immunostaining in alveolar walls, the immunostaining of Dectin?1 can last for two weeks. The posi?tive particles were mainly located in cytoplasm and membrane of epithelial cells. In contrast, mice treated with PBS or Ad?EGFP did not detected immunostaining in the lungs. Immunostaining results showed time?dependent change of average optical density with peak reach at day 5 after administration. We used confocal microscopy to detect the green fluorescent protein which can emit green fluorescence under excitation of 488nm laser. We found green fluorescence in lung but not in liver. Results of ELISA showed no significantly differences of levels of IL?6 were founded compared with mice treated with Ad?EGFP or PBS. Pathology of lung tissue of mice treated with Ad?mDectin?1 showed mild inflammation reaction, characterized by polymorphonuclear cells infiltration at 3 day post?infection and peribronchial lymphocytes hyperplasia after 3 days. Necrosis and structure changes were not found. CONCLUSION: After intratracheal administration of Ad?mDectin?1, the expression of Dectin?1 in the lungs of mice is successful upregulated. Location of Dectin?1 is mainly on airways epithelium in bronchioles. The peak of expression of Dectin?1 is at day 5 after administration of Ad?mDectin?1, expression of Dectin?1 can last for more than two weeks. After intratracheal of administra?tion of Ad?mDectin?1, no significant adverse effect and obvious inflammatory reaction are observed. Adenovirus vector is mainly located in lung and does not spread to liver of distant organ.

Antimicrobial peptide CAMA‐syn expressed in pulmonary epithelium by recombination adenovirus inhibited the growth of intracellular bacteria

Bomidin: an Optimized Antimicrobial Peptide with Broad Antiviral Activity Against Enveloped Viruses.

Cpg7909 Adjuvant Enhanced Immunogenicity Efficacy In Mice Immunized With Esat6-Ag85a Fusion Protein, But Does Not Confer Significant Protection Against Mycobacterium Tuberculosis Infection

Single-Dose Mucosal Immunotherapy with Chimpanzee Adenovirus-Based Vaccine Accelerates Tuberculosis Disease Control and Limits Its Rebound after Antibiotic Cessation

A Recombinant Adenovirus Expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium Tuberculosis Elicits Strong Antigen-Specific Immune Responses in Mice.

Synthetic antimicrobial peptides Bac-5, BMAP-28, and Syn-1 can inhibit bovine respiratory disease pathogens in vitro

Study on identification and security of the murine model administrated with recombi-nant adenovirus encoding murine Dectin-1

Intranasal Immunization with a Recombinant Adenovirus Encoding Multi-Stage Antigens of Mycobacterium tuberculosis Preferentially Elicited CD8+ T Cell Immunity and Conferred a Superior Protection in the Lungs of Mice than Bacillus Calmette-Guerin

A novel cathelicidin TS-CATH derived from Thamnophis sirtalis combats drug-resistant gram-negative bacteria in vitro and in vivo

Preparation of murine lung cancer vaccine modified by macrophagic inflammatory protein 1αand observational study of antitumor activity in vivo

Inhibition of Allergic Responsiveness in a Murine Asthma Model Via IFN-gamma Transgene Expression.

Activities of a Broad-Spectrum Antimicrobial Peptide Analogue SAMP-A4-C8 and Its Combat Against Pneumonia in Staphylococcus Aureus-Infected Mice.

The Antimicrobial Peptide Cathelicidin-Bf Could Be A Potential Therapeutic for Salmonella Typhimurium Infection

Genetically Engineered Distal Airway Stem Cell Transplantation Protects Mice from Pulmonary Infection

In vitro and in vivo studies on the inhibitory effects of myocardial cell culture medium on growth of a human lung adenocarcinoma cell line, A549.

The Antimicrobial Peptide MPX Kills Actinobacillus Pleuropneumoniae and Reduces Its Pathogenicity in Mice.

Antimicrobial peptide DvAMP combats carbapenem-resistant Acinetobacter baumannii infection

Antimicrobial Peptide Cec4 Eradicates Multidrug-Resistant Acinetobacter baumannii in vitro and in vivo

The Inhibitory Effect of Conditionally Replicating Adenovirus Combined with Mitomycin on the Proliferation of Bladder Cancer Cells

Human mesenchymal stromal cells inhibit Mycobacterium avium replication in clinically relevant models of lung infection

Antibacterial and Antifungal Properties of a Novel Antimicrobial Peptide GK-19 and Its Application in Skin and Soft Tissue Infections Induced by MRSA or Candida albicans